Back to MLTX
CITADEL ADVISORS LLC MLTX Position History
MoonLake Immunotherapeutics • Healthcare
Quarters held
53
Latest value
$1.9M
Q3 2026
Peak value
$120.8M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $62.5M |
| Q2 2023 | $103.1M |
| Q3 2023 | $1.2M |
| Q3 2023 | $1.9M |
| Q3 2023 | $114M |
| Q3 2023 | $2M |
| Q4 2023 | $1.5M |
| Q4 2023 | $2.9M |
| Q4 2023 | $120.8M |
| Q4 2023 | $523K |
| Q1 2024 | $1.5M |
| Q1 2024 | $1.3M |
| Q1 2024 | $113.8M |
| Q1 2024 | $2.2M |
| Q2 2024 | $761K |
| Q2 2024 | $638K |
| Q2 2024 | $99.6M |
| Q2 2024 | $3K |
| Q3 2024 | $666K |
| Q3 2024 | $529K |
| Q3 2024 | $114.2M |
| Q3 2024 | $2.9M |
| Q4 2024 | $623K |
| Q4 2024 | $958K |
| Q4 2024 | $118.4M |
| Q4 2024 | $67K |
| Q1 2025 | $356K |
| Q1 2025 | $379K |
| Q1 2025 | $56.4M |
| Q1 2025 | $1.3M |
| Q2 2025 | $71.4M |
| Q2 2025 | $1.3M |
| Q2 2025 | $7.6M |
| Q2 2025 | $892K |
| Q3 2025 | $2.2M |
| Q3 2025 | $354K |
| Q3 2025 | $1.4M |
| Q4 2025 | $479K |
| Q4 2025 | $19.7M |
| Q4 2025 | $4.5M |
| Q4 2025 | $5.6M |
| Q1 2026 | $12.4M |
| Q1 2026 | $24.7M |
| Q1 2026 | $1.8M |
| Q2 2026 | $5.3M |
| Q2 2026 | $38.4M |
| Q2 2026 | $4.1M |
| Q2 2026 | $5.3M |
| Q2 2026 | $38.4M |
| Q2 2026 | $4.1M |
| Q3 2026 | $5.4M |
| Q3 2026 | $20M |
| Q3 2026 | $1.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.9M | 161.7K | — | — |
| Q3 2026 | $20M | 1.71M | — | — |
| Q3 2026 | $5.4M | 465.7K | — | — |
| Q2 2026 | $4.1M | 211.8K | — | — |
| Q2 2026 | $38.4M | 1.97M | — | — |
| Q2 2026 | $5.3M | 273.1K | — | — |
| Q2 2026 | $4.1M | 211.8K | — | — |
| Q2 2026 | $38.4M | 1.97M | — | — |
| Q2 2026 | $5.3M | 273.1K | — | — |
| Q1 2026 | $1.8M | 94.0K | — | — |
| Q1 2026 | $24.7M | 1.32M | — | — |
| Q1 2026 | $12.4M | 664.0K | — | — |
| Q4 2025 | $5.6M | 421.6K | — | — |
| Q4 2025 | $4.5M | 344.6K | — | — |
| Q4 2025 | $19.7M | 1.49M | — | — |
| Q4 2025 | $479K | 36.3K | — | — |
| Q3 2025 | $1.4M | 195.6K | — | — |
| Q3 2025 | $354K | 49.3K | — | — |
| Q3 2025 | $2.2M | 303.2K | — | — |
| Q2 2025 | $892K | 18.9K | — | — |
| Q2 2025 | $7.6M | 161.0K | — | — |
| Q2 2025 | $1.3M | 26.6K | — | — |
| Q2 2025 | $71.4M | 1.51M | — | — |
| Q1 2025 | $1.3M | 34.5K | — | — |
| Q1 2025 | $56.4M | 1.44M | — | — |
| Q1 2025 | $379K | 9.7K | — | — |
| Q1 2025 | $356K | 9.1K | — | — |
| Q4 2024 | $67K | 1.2K | — | — |
| Q4 2024 | $118.4M | 2.19M | — | — |
| Q4 2024 | $958K | 17.7K | — | — |
| Q4 2024 | $623K | 11.5K | — | — |
| Q3 2024 | $2.9M | 57.3K | — | — |
| Q3 2024 | $114.2M | 2.27M | — | — |
| Q3 2024 | $529K | 10.5K | — | — |
| Q3 2024 | $666K | 13.2K | — | — |
| Q2 2024 | $3K | 70 | — | — |
| Q2 2024 | $99.6M | 2.27M | — | — |
| Q2 2024 | $638K | 14.5K | — | — |
| Q2 2024 | $761K | 17.3K | — | — |
| Q1 2024 | $2.2M | 43.8K | — | — |
| Q1 2024 | $113.8M | 2.27M | — | — |
| Q1 2024 | $1.3M | 25.3K | — | — |
| Q1 2024 | $1.5M | 30.2K | — | — |
| Q4 2023 | $523K | 8.7K | — | — |
| Q4 2023 | $120.8M | 2.00M | — | — |
| Q4 2023 | $2.9M | 47.8K | — | — |
| Q4 2023 | $1.5M | 25.6K | — | — |
| Q3 2023 | $2M | 34.4K | — | — |
| Q3 2023 | $114M | 2.00M | — | — |
| Q3 2023 | $1.9M | 34.1K | — | — |
| Q3 2023 | $1.2M | 21.6K | — | — |
| Q2 2023 | $103.1M | 2.02M | — | — |
| Q1 2023 | $62.5M | 2.92M | — | — |
Other funds holding MLTX
$311.5M
$298.3M
$260.3M
$256.4M
$192.9M
$191.2M
$187.2M
$182.6M